The polystyrene leader's revenue soared 78% from a weak base, but profit fell sharply as the exceptional spreads of last quarter evaporated.
Supreme Petrochem's Q2 FY27 tells two stories: revenue surged 77.5% year-on-year, yet profit fell 59% sequentially. The gap highlights a return to normal margins after an unsustainable spike, with management's prediction of normalization playing out exactly.
For Supreme Petrochem, the story of Q2 FY27 is a return to earth. The polystyrene leader's revenue surged from a depressed year-ago base, but the real shift was in profitability, which retreated sharply from an unsustainable peak. The quarter delivered exactly the margin normalization management had warned about, framing growth within the company's historical band of returns.
Revenue for the September quarter hit ₹1,983.5 crore, a 77.5% jump from a weak Q2 FY26. Profit after tax more than doubled year-on-year to ₹97.2 crore. Sequentially, however, profit collapsed by 59% even as revenue grew 15.7%. The net profit margin compressed to 4.9% from an exceptional 13.9% in the June quarter.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 1,983.51YoY +77% | 1,714.52 | 1,117.76 |
| Profit (₹ Cr) | 97.15YoY +100% | 237.57 | 48.47 |
| Net Profit Margin (%) | 4.9YoY +14% | 13.9 | 4.3 |
The dramatic sequential profit drop was entirely margin-driven. According to a StockWatch analysis, the net profit margin compressed by nearly 900 basis points as operating margins normalized to 7.7% from 19.4% in Q1. Management had explicitly flagged this on the previous quarter's call, noting that Q1's unusually wide spreads between styrene monomer and downstream polymers were an 'aberration' expected to normalize.
This quarter's margin profile, in fact, is closer to the company's historical norm and slightly above the year-ago level. The story is not one of sudden weakness but of a reversion from an unsustainable high. The revenue growth, as noted by Sahi.com, was driven by resilient domestic demand for styrenics, though it came against a backdrop of significant volume declines in prior periods.
With margins back in a more typical range, the question is where they settle next. Management refrained from giving formal FY27 volume guidance, citing uncertainty from West Asia conflicts and styrene price volatility. The company is advancing a significant ₹900 crore capacity expansion funded by internal accruals, including a new polystyrene line to be completed by December 2028.
Near-term profitability will be dictated by the styrene-polymer delta and input cost management. Reports highlight risks from volatile crude oil and styrene monomer pricing, as well as potential import competition. The company's balance sheet strength, with zero debt and a current ratio above 2, provides stability to fund its growth plans through this cycle.
Key Points
This quarter confirms that Supreme Petrochem's earnings power resides in a mid-single-digit net margin band, not the teens printed last quarter. The valuation, at a P/E of 42 against an industry average of 14, prices in leadership but may struggle to justify if margins merely hold at this normalized level.
The path forward depends on whether domestic demand can absorb new capacity and if management can navigate styrene cost volatility better than peers. The zero-debt balance sheet is a clear advantage, allowing internal funding for growth without pressure. Investors are now weighing solid underlying demand against the reality of cyclical, commodity-linked margins.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.